Precision Medicine with Antibody Photosensitizer Conjugates
Antibody photosensitizer conjugates (APCs) herald a new era in precision-targeted therapies, merging monoclonal antibodies and photosensitizers to enhance cancer treatment effectiveness while reducing collateral damage to healthy tissues. With applications ranging from photoimmunotherapy to potential viral infection treatments, APCs hold promise in revolutionizing precision medicine’s landscape. Innovative Antibody Photosensitizer Conjugates for Targeted Therapy Antibody photosensitizer […]
3 minute read